Market Introduction
Sequencing reagents are used during the process of sequencing. The use of these reagents highly depends on the desired result to be obtained. They form an essential part of the sequencing reactions, which can be used across various other applications as well.
Market Overview and Dynamics
The Asia Pacific sequencing reagents market is expected to reach US$ 3,330.10 million by 2028 from US$ 1,392.13 million in 2021; it is estimated to grow at a CAGR of 13.3% from 2021 to 2028. The growth of the market is attributed to the increasing demand for third generation sequencing and personalized medicines. However, the dearth of skilled professionals hinders the market growth.
Genomic sequencing technologies have revolutionized mutation detection of the genetic diseases in the past few years. In recent years, the third-generation sequencing (TGS) has been gaining insight into more genetic diseases, owing to the single molecular and real time sequencing technology. One of these new technologies was developed by Pacific Biosciences and is called Single-Molecule Sequencing in Real Time (SMRT). SMRT is very efficient, which means that fewer expensive chemicals must be used. It is also incredibly sensitive, enabling scientists to effectively ‘eavesdrop’ on DNA polymerase and observe it making a strand of DNA. A rise in the demand for third-generation sequencing (TGS) technologies is attributive to the lucrative growth rate of this segment. With the emergence of TGS, genome sequencing has become a faster and reliable method to study genomic variations. Also, personalized medicine offers the most promising approaches to tackle diseases, which have far eluded effective treatments or cures. Increasing adoption of personalized medicines for disease treatments using the patient’s genetic information is expected to aid in offering targeted treatment. This, in turn, is expected to create lucrative growth opportunities for the sequencing reagent market during the forecast period.
Asia Pacific is adversely affected by COVID-19 pandemic. The genomics helped understand SARS-CoV-2, which enabled governments and researchers to track the emergence of COVID-19 outbreaks in their country. Healthcare experts realized the importance of genomics in the treatment of COVID-19, which is expected to raise the demand for genomic during the forecast period. Hence, the rising research activities on the novel coronavirus that causes COVID-19 are paving a way for potential opportunities for start-ups and established businesses. For instance, Haystack Analytics, a start-up company in Mumbai, India, is using genomics to study the transmission of the coronavirus to help the Indian government. Thus, the demand for genomics is increasing due to the rising cases of COVID-19. As a result, the need for sequencing reagents is growing, which is driving the growth of the market.
Key Market Segments
The Asia Pacific sequencing reagents market, by technology, is segmented into next generation sequencing, sanger sequencing, and third generation sequencing. The next generation sequencing segment held the largest share of the market in 2020. However, the sanger sequencing segment is anticipated to register the highest CAGR in the market during the forecast period.
The Asia Pacific sequencing reagents market, by reagent type, is segmented into control kits, library kits, template kits, sequencing kits, and other reagent types. The sequencing kits segment held the largest share of the market in 2020, whereas the library kits segment is anticipated to register the highest CAGR in the market during the forecast period.
The Asia Pacific sequencing reagents market, by application, is segmented into agrigenomics and forensics, clinical investigation, oncology, reproductive health, and other applications. The oncology segment held the largest share of the market in 2020. However, the clinical investigation segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Asia Pacific sequencing reagents market are Japan Agency for Medical Research and Development (AMED), Genomics Health Futures Mission and World Health Organization (WHO).
Reasons to buy the report
ASIA PACIFIC SEQUENCING REAGENTS MARKET SEGMENTATION
By Technology
By Reagent Type
By Application
By End User
By Country
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,392.13 Million |
| Market Size by 2028 | US$ 3,330.10 Million |
| CAGR (2021 - 2028) | 13.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Sequencing Reagents Market is valued at US$ 1,392.13 Million in 2021, it is projected to reach US$ 3,330.10 Million by 2028.
As per our report Asia Pacific Sequencing Reagents Market, the market size is valued at US$ 1,392.13 Million in 2021, projecting it to reach US$ 3,330.10 Million by 2028. This translates to a CAGR of approximately 13.3% during the forecast period.
The Asia Pacific Sequencing Reagents Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Sequencing Reagents Market report:
The Asia Pacific Sequencing Reagents Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Sequencing Reagents Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Sequencing Reagents Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)